|
1
|
Bruix J, Reig M and Sherman M:
Evidence-based diagnosis, staging, and treatment of patients with
hepatocellular carcinoma. Gastroenterology. 150:835–853. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sileri P, D'Ugo S, Benavoli D, Stolfi VM,
Palmieri G, Mele A and Gaspari AL: Metachronous splenic metastasis
from colonic carcinoma five-years after surgery: A case report and
literature review. South Med J. 102:733–735. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang MQ, Lin X, Li Y and Lu S: Irinotecan
as a second-line chemotherapy for small cell lung cancer: A
systemic analysis. Asian Pac J Cancer Prev. 16:1993–1995. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Phelps MA and Sparreboom A: Irinotecan
pharmacogenetics: A finished puzzle? J Clin Oncol. 32:2287–2289.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takeno S, Noguchi T, Kikuchi R, Uchida Y,
Yokoyama S and Müller W: Prognostic value of cyclin B1 in patients
with esophageal squamous cell carcinoma. Cancer. 94:2874–2881.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wei SY, Chen Y and Xu XY: Progress on the
pharmacological research of puerarin: A review. Chin J Nat Med.
12:407–414. 2014.PubMed/NCBI
|
|
7
|
Maji AK, Pandit S, Banerji P and Banerjee
D: Pueraria tuberosa: A review on its phytochemical and therapeutic
potential. Nat Prod Res. 28:2111–2127. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang J, Yang ZR, Guo XF, Song J, Zhang JX,
Wang J and Dong WG: Synergistic effects of puerarin combined with
5-fluorouracil on esophageal cancer. Mol Med Rep. 10:2535–2541.
2014.PubMed/NCBI
|
|
9
|
Tang W, Zhu J, Su S, Wu W, Liu Q, Su F and
Yu F: MiR-27 as a prognostic marker for breast cancer progression
and patient survival. PLoS One. 7:e517022012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakagawa H, Umemura A, Taniguchi K,
Font-Burgada J, Dhar D, Ogata H, Zhong Z, Valasek MA, Seki E,
Hidalgo J, et al: ER stress cooperates with hypernutrition to
trigger TNF-dependent spontaneous HCC development. Cancer Cell.
26:331–343. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Le Sage C and Agami R: Immense promises
for tiny molecules: Uncovering miRNA functions. Cell Cycle.
5:1415–1421. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Croker BA, O'Donnell JA, Nowell CJ,
Metcalf D, Dewson G, Campbell KJ, Rogers KL, Hu Y, Smyth GK, Zhang
JG, et al: Fas-mediated neutrophil apoptosis is accelerated by Bid,
Bak, and Bax and inhibited by Bcl-2 and Mcl-1. Proc Natl Acad Sci
USA. 108:pp. 13135–13140. 2011; View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhai D, Jin C, Huang Z, Satterthwait AC
and Reed JC: Differential regulation of Bax and Bak by
anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1. J Biol Chem.
283:9580–9586. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Krishna S, Low IC and Pervaiz S:
Regulation of mitochondrial metabolism: Yet another facet in the
biology of the oncoprotein Bcl-2. Biochem J. 435:545–551. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer. 96
Suppl:R40–R44. 2007.PubMed/NCBI
|
|
16
|
Zhang J, Du Y, Wu C, Ren X, Ti X, Shi J,
Zhao F and Yin H: Curcumin promotes apoptosis in human lung
adenocarcinoma cells through miR-186* signaling pathway. Oncol Rep.
24:1217–1223. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xi S, Dyer KF, Kimak M, Zhang Q, Gooding
WE, Chaillet JR, Chai RL, Ferrell RE, Zamboni B, Hunt J, et al:
Decreased STAT1 expression by promoter methylation in squamous cell
carcinogenesis. J Natl Cancer Inst. 98:181–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Neri M, Betta P, Marroni P, Filiberti R,
Cafferata M, Mereu C, Ivaldi G, Montanaro F, Puntoni R and
Paganuzzi M: Serum anti-p53 autoantibodies in pleural malignant
mesothelioma, lung cancer and non-neoplastic lung diseases. Lung
Cancer. 39:165–172. 2003. View Article : Google Scholar : PubMed/NCBI
|
